Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Journal article
Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis.
Angus, Derek C Linde-Zwirble, Walter T Clermont, Gilles Ball, Daniel E Basson, Bruce R Ely, E Wesley Laterre, Pierre-François[UCL] Vincent, Jean-Louis Bernard, Gordon van Hout, Ben PROWESS Investigators (2003) Critical Care Medicine — Vol. 31, no.1, p. 1-11 (2003)
- Journal article
Efficacy and safety of recombinant human activated protein C for severe sepsis.
Bernard, Gordon R Vincent, Jean-Louis Laterre, Pierre-François[UCL] La Rosa, Steven P Dhainaut, Jean-François Lopez-Rodriguez, Angel Steingrub, Jay S Garber, GaryE Helterbrand, Jeffrey D Ely, E Wesley Fisher, Charles J Hantson, Philippe[UCL] Reynaert, Marc[UCL] Wittebole, Xavier[UCL] the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group (2001) New England Journal of Medicine — Vol. 344, no. 10, p. 699-709 (2001)